Convergent Biotechnologies Private Limited
About Convergent Biotechnologies Private Limited
Data last updated:
Convergent Biotechnologies Private Limited is a private limited company based in Chandigarh, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 24 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH2005PTC028449. Its GSTIN is 04AACCC6012F1ZC (Chandigarh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chander Kanta Bhalla and Rajesh Malhotra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # 5188/3 M.H.C.Manimajra Chandigarh, Chandigarh, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹20,411, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹86,759 (net margin -425.1%) and EBITDA of -₹76,826 (EBITDA margin -376.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 40% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Convergent Biotechnologies Private Limited's registered office is in Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address# 5188/3 M.H.C.Manimajra Chandigarh, Chandigarh, India
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Convergent Biotechnologies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Convergent Biotechnologies Private Limited
FY 2025 filings availableConvergent Biotechnologies Private Limited reported revenue of ₹20,411 (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 40%. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹76,826 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹86,759 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -376.4% | ||||
| Net Profit Margin | -425.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Convergent Biotechnologies Private Limited, buy the company report.
Board of directors of Convergent Biotechnologies Private Limited
Convergent Biotechnologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chander Kanta Bhalla | Director | 24 May 2005 | 21 Years 5 Months | Current |
| Rajesh Malhotra Also directs: Convergys Healthcare Private Limited | Director | 24 May 2005 | 21 Years 5 Months | Current |
Peer comparison
Convergent Biotechnologies Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avante Life Tech Private Limited | ₹21,977 (FY 2020) | -95.0% | Chennai, Tamil Nadu, India | |||
| Galactic Pharmaceuticals Private Limited | ₹21,871 (FY 2019) | Yavatmal, Maharashtra, India | ||||
| Sibre Systems & Services Private Limited | ₹21,657 (FY 2024) | 2066.0% | Chennai, Tamil Nadu, India | |||
| Endaxi Health Care Private Limited | ₹21,150 (FY 2024) | Patna, Bihar, India | ||||
| Sarvarth Udyog Private Limited | ₹20,500 (FY 2025) | Raipur, Chhattisgarh, India | ||||
| Convergent Biotechnologies Private Limitedthis company | ₹20,411 (FY 2024) | -₹86,759 | -425.1% | 24.0% | Chandigarh, India | |
| Harakchand International Pvt Ltd | ₹19,800 (FY 2025) | -70.0% | New Delhi, Delhi, India | |||
| Quantum Biologicals Private Limited | ₹19,784 (FY 2023) | Road, Chennai-96, Tamil Nadu, India | ||||
| Glomi Naturals Private Limited | ₹19,755 (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Rudhran Healthcare Supplies Private Limited | ₹19,585 (FY 2021) | Bangalore, Karnataka, India | ||||
| Agniroth Photonics Private Limited | ₹18,831 (FY 2025) | Bardhaman, West Bengal, India |
To see the full peer comparison of Convergent Biotechnologies Private Limited, buy the company report.
Auditor
Convergent Biotechnologies Private Limited is audited by K J M A & ASSOCIATES for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K J M A & ASSOCIATES | FY 2015 | 010895N |
Shareholding
The shareholding of Convergent Biotechnologies Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Convergent Biotechnologies Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Convergent Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Convergent Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Convergent Biotechnologies has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCC6012F1ZC | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Convergent Biotechnologies Private Limited, buy the company report.
Recent activity
Convergent Biotechnologies Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Chander Kanta Bhalla was appointed as Director on 24 May 2005.
Frequently asked questions
Convergent Biotechnologies is an active private limited company based in Chandigarh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 24 May 2005 (21+ years old) and is registered under CIN U24231CH2005PTC028449.
Convergent Biotechnologies has 2 current directors:
- Chander Kanta Bhalla - Director
- Rajesh Malhotra - Director
The latest financial statements of Convergent Biotechnologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Convergent Biotechnologies is 04AACCC6012F1ZC, registered in Chandigarh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Convergent Biotechnologies is U24231CH2005PTC028449. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Convergent Biotechnologies was incorporated on 24 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Convergent Biotechnologies by revenue are Avante Life Tech Private Limited, Galactic Pharmaceuticals Private Limited, Sibre Systems & Services Private Limited, Endaxi Health Care Private Limited, Sarvarth Udyog Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Chander Kanta Bhalla was appointed as Director on 24 May 2005. Rajesh Malhotra was appointed as Director on 24 May 2005.
The registered office of Convergent Biotechnologies is at # 51883 M.H.C.Manimajra Chandigarh, Chandigarh, India.
Convergent Biotechnologies operates in the healthcare industry, in the medical equipment retail and distribution segment.
The compliance status of Convergent Biotechnologies is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
